In Lithuania, enzyme design startup Biomatter has secured €6.5 million in a seed financing round to expand its generative AI platform for developing new enzymes faster.
Biomatter develops custom enzymes for chemicals production, agriculture, food and medicine. Its customers include chemicals giant BASF and Neogen. “The enzymes we have developed show that we can go far beyond optimizing known enzymes. Our ability to design fundamentally new enzymes will contribute to a better future,” Laurynas Karpus, co-founder and CEO of Biomatter, tells EU Startups
The funding round was led by UVC Partners and Inventure VC. Practica Capital, Metaplanet and several business angels and industry experts also participated.
“Biomatter’s innovative approach makes it possible to break through the boundaries of natural enzymes and leads to breakthroughs in biotechnology. We are impressed by the strength of the team and convinced that Biomatter is a pioneer in the field of AI-based protein design,” said Dr. Oliver Schoppe, from UVC Partners.
{Categories} _Category: Platforms{/Categories}
{URL}https://www.biofuelsdigest.com/bdigest/biomatter-raises-e6-5-million-to-boost-ai-capabilities/{/URL}
{Author}Rebecca Gendron{/Author}
{Image}{/Image}
{Keywords}Chemicals & Materials,Biomatter,Lithuania{/Keywords}
{Source}Platforms{/Source}
{Thumb}{/Thumb}